Copper regulation evaluation and therapy

Details for Australian Patent Application No. 2006240568 (hide)

Owner Protemix Corporation Limited

Inventors Cooper, Garth James Smith

Agent A J Park

Pub. Number AU-A-2006240568

PCT Pub. Number WO2006/115421

Priority 60/674,734 25.04.05 US; 60/675,310 26.04.05 US

Filing date 26 April 2006

Wipo publication date 2 November 2006

International Classifications

G01N 33/72 (2006.01) Investigating or analysing materials by specific methods not covered by groups - involving blood pigments, e.g. hemoglobin, bilirubin

G01N 33/573 (2006.01) Investigating or analysing materials by specific methods not covered by groups - for enzymes or isoenzymes

Event Publications

6 December 2007 PCT application entered the National Phase

  PCT publication WO2006/115421 Priority application(s): WO2006/115421

16 June 2011 Assignment before Grant

  Protemix Corporation Limited The application has been assigned to Philera New Zealand Limited

24 November 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006240570-A flow switch

2006240567-Lipid encapsulation